Tissue engineering-based approaches have the potential to improve stem cell engraftment by increasing cell delivery to the myocardium. Our objective was to develop and characterize a naturally-derived, autologous, biodegradable
hydrogel in order to improve acute stem cell retention in the myocardium. HA-blood
hydrogels (HA-BL) were synthesized by mixing in a 1:1(v/v) ratio, lysed whole blood and
hyaluronic acid (HA), whose carboxyl groups were functionalized with
N-hydroxysuccinimide (NHS) to yield HA succinimidyl
succinate (HA-NHS). We performed physical characterization and measured survival/proliferation of cardiosphere-derived cells (
CDCs) encapsulated in the
hydrogels.
Hydrogels were injected intra-myocardially or applied epicardially in rats. NHS-activated carboxyl groups in HA react with primary
amines present in blood and myocardium to form
amide bonds, resulting in a 3D
hydrogel bound to tissue. HA-blood
hydrogels had a gelation time of 58±12 s, swelling ratio of 10±0.5, compressive and elastic modulus of 14±3 and 1.75±0.6 kPa respectively. These
hydrogels were not degraded at 4 wks by hydrolysis alone. CDC encapsulation promoted their survival and proliferation. Intra-myocardial injection of
CDCs encapsulated in these
hydrogels greatly increased acute myocardial retention (p=0.001). Epicardial application of HA-blood
hydrogels improved left ventricular ejection fraction following
myocardial infarction (p=0.01). HA-blood
hydrogels are highly adhesive, biodegradable, promote CDC survival and increase cardiac function following epicardial application after
myocardial infarction.